 CAMBRIDGE, Mass.-- BUSINESS WIRE --Sage Therapeutics, Inc. Nasdaq: SAGE and Biogen Inc. Nasdaq: BIIB today announced that the companies will host a joint investor webcast to discuss the planned commercialization approach and opportunity for their investigational product, zuranolone, on Tuesday, December 6 at 8:00 a.m. ET. 